Brief: Lantheus Holdings Q2 Adjusted EPS USD 1.8 Vs. IBES Estimate USD 1.83
31/07/2024 12:00
Jul 31 (Reuters) - Lantheus Holdings Q2 revenue USD 394.1 million vs. IBES estimate USD 382.2 million. * Q2 EPS USD 0.88
Recent news on Lantheus Holdings
See all newsStreet View: Lantheus' tumor kit setback seen as temporary, with growth catalysts still ahead
Brief: Lantheus Receives Complete Response Letter From FDA For Lnth-2501 (Ga 68 Edotreotide)
US FDA declines Lantheus’ tumor imaging kit over third-party manufacturing issues (updated)
US FDA declines to approve Lantheus’ tumor imaging kit
$7 billion could be a 'light' price tag for Lantheus, Truist analysts say